WE SELL NOTHING✳EVERY CLAIM → A PRIMARY SOURCE✳UNKNOWN IS A REAL ANSWER✳NO PRODUCTS · NO PROTOCOLS · NO VENDORS✳EDUCATIONAL JOURNALISM · NOT MEDICAL ADVICE✳ WE SELL NOTHING✳EVERY CLAIM → A PRIMARY SOURCE✳UNKNOWN IS A REAL ANSWER✳NO PRODUCTS · NO PROTOCOLS · NO VENDORS✳EDUCATIONAL JOURNALISM · NOT MEDICAL ADVICE✳
The Peptide Current FDA Peptide Tracker
Official sources checked July 25, 2026
FDA Peptide TrackerLast checked · July 25, 2026

Seven peptide decisions, without the headline fog.

All 14 form-specific votes are recorded from FDA's voting questions and FDA-linked archived broadcasts. The committee recommended inclusion for 6 peptide groups and against inclusion for 1; FDA's final determinations remain separate and pending.

Right now
The committee votes are complete. FDA’s final action is not.
  • Staff · 7 against
  • Committee · 6 recommend inclusion · 1 against
  • Final FDA action · 0
How to read this FDA tracker

There are three separate decisions.

A headline may say “FDA says no,” but the public record moves through three different stages. This page shows exactly which one has happened.

Stage 1 · completeFDA staff’s analysis appears in the public briefing packets.
Stage 2 · completePCAC recorded 14 form-specific advisory votes on July 23–24.
Stage 3 · pendingFDA considers the non-binding advice and completes its review.
Day 1 · July 23

Four peptide groups

8 votes · all recommended inclusion

BPC-157

PCAC: Recommend inclusion
FDA staff
published
Committee
recorded
Final FDA
pending

Uses FDA reviewed: Ulcerative colitis

Two form-specific votes: BPC-157 (free base): Yes 8, No 6, Abstain 1. BPC-157 acetate: Yes 8, No 6, Abstain 1.

Open the FDA file →

KPV

PCAC: Recommend inclusion
FDA staff
published
Committee
recorded
Final FDA
pending

Uses FDA reviewed: Wound healing · Inflammatory conditions

Two form-specific votes: KPV (free base): Yes 8, No 6, Abstain 1. KPV acetate: Yes 8, No 6, Abstain 1.

Open the FDA file →

TB-500

PCAC: Recommend inclusion
FDA staff
published
Committee
recorded
Final FDA
pending

Uses FDA reviewed: Wound healing

Two form-specific votes: TB-500 (free base): Yes 8, No 6, Abstain 1. TB-500 acetate: Yes 8, No 6, Abstain 1.

Open the FDA file →

MOTS-c

PCAC: Recommend inclusion
FDA staff
published
Committee
recorded
Final FDA
pending

Uses FDA reviewed: Obesity · Osteoporosis

Two form-specific votes: MOTS-c (free base): Yes 7, No 5, Abstain 2. MOTS-c acetate: Yes 7, No 5, Abstain 2.

Open the FDA file →
Day 2 · July 24

Three peptide groups

6 votes · 2 groups in · 1 group against

Emideltide / DSIP

PCAC: Recommend against
FDA staff
published
Committee
recorded
Final FDA
pending

Uses FDA reviewed: Opioid withdrawal · Chronic insomnia · Narcolepsy

Two form-specific votes: Emideltide (free base): Yes 6, No 7, Abstain 1. Emideltide acetate: Yes 6, No 7, Abstain 1.

Open the FDA file →

Semax

PCAC: Recommend inclusion
FDA staff
published
Committee
recorded
Final FDA
pending

Uses FDA reviewed: Cerebral ischemia · Migraine · Trigeminal neuralgia

Two form-specific votes: Semax (free base): Yes 8, No 5, Abstain 1. Semax acetate: Yes 8, No 5, Abstain 1.

Open the FDA file →

Epitalon

PCAC: Recommend inclusion
FDA staff
published
Committee
recorded
Final FDA
pending

Uses FDA reviewed: Insomnia

Two form-specific votes: Epitalon (free base): Yes 7, No 4, Abstain 1. Epitalon acetate: Yes 7, No 4, Abstain 1.

Open the FDA file →
Scope: This tracker explains a public regulatory process. It is not a recommendation, a legal-status database for individual products, or medical advice.
If someone may be having a medical problem

Get help first. Report later.

PepCurrent cannot assess symptoms or provide emergency triage.

Call 911 nowIf someone collapses, has a seizure, has trouble breathing, or cannot be awakened.
U.S. Poison ControlCall 1-800-222-1222 or visit Poison.org.
Personal medical questionsContact a licensed clinician who can evaluate the person and their medical history.
Serious product problemAfter appropriate care, patients and clinicians can use FDA MedWatch.

U.S. resources · checked July 16, 2026 · Open the full Help Now page →

Primary record
FDA meeting page, materials, and linked broadcastsOfficial page ↗FDA voting questions — all 14 form-specific questionsOfficial PDF ↗FDA briefing introductionOfficial PDF ↗